SCHEMBL20049335

SCHEMBL20049335

Cc1nc2c(C)cc(C(C)C)cc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.41
HSD17B10 Q99714 3/20 0.41
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
SCN4A P35499 1/20 0.38
TSHR P16473 1/20 0.36
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
ADRA1D P25100 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25749135 0.84 NPC1 (0.38) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL20667373 0.82 ALDH1A1 (0.39) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL11785426 0.82 HSD17B10 (0.39) HSD17B10NPC1RAB9ASMN1; SMN2SCN4A
SCHEMBL20049190 0.82 SMN1; SMN2 (0.42) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL12109865 0.82 NPC1 (0.37) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL25492745 0.82 RAB9A (0.37) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL21097668 0.80 MAPT (0.48) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL23502448 0.80 HSD17B10 (0.37) HSD17B10NPC1RAB9ASMN1; SMN2SCN4A
SCHEMBL21098342 0.77 CHRNB2 (0.35) GAAHSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL25111970 0.77 GAA (0.44) GAAHSD17B10NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 WO disclosed